The Latest Breaking News on COVID-19

On Wednesday, Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) announced data from a post hoc analysis of the GALE extension study following five years of continuous treatment with Syfovre (pegcetacoplan injection) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

AnaptysBio Inc. (NASDAQ:ANAB) on Monday released data from the Phase 2 trial of rosnilimab for moderate-to-severe ulcerative colitis.

There were 502 cases of whooping cough between January and June this year in England, according to UKHSA

It comes amid previous concerns about potential harm from the jab

Previously, fall is when Americans would typically receive their vaccines

YOUR VIEWS: Our community has criticised the government’s decision to restrict free Covid boosters, describing it as unfair, confusing, and short-sighted, and urged a review of eligibility to protect vulnerable people still at risk

Only a few years after first being detected in Australia, nitazenes have been found in everything from vapes to fake heroin – and the death toll is rising

Risk to general public is low but cases in California suggest virus is spreading undetected in some communities

Meningitis can cause life-threatening sepsis and result in permanent damage to the brain or nerves if not treated quickly

Young people are eschewing medical trials, to their own detriment. Maybe my tales of pills, tubes and paydays can inspire a generation, says freelance writer Rich Pelley

Critics say scientists ‘held hostage’ by RFK Jr as changes mean vaccine development and guidance in peril